S.12.02 Absence of D-serine results in abnormal dopamine–glutamate dialogue in the prefrontal cortex
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
European neuropsychopharmacology - 24(2014), 2, SUPPL vom: Okt., Seite 1-1 |
| Beteiligte Personen: |
Dallerac, G. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
1 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1951504801 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1951504801 | ||
| 003 | DE-627 | ||
| 005 | 20230514085439.0 | ||
| 007 | tu | ||
| 008 | 140929s2014 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw140926_1 |
| 035 | |a (DE-627)OLC1951504801 | ||
| 035 | |a (DE-599)GBVOLC1951504801 | ||
| 035 | |a (KEY)0206078720141000024000200001s1202absenceofdserineresultsinabnormaldopamineglut | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 150 |a 610 |
| 084 | |a 77.00 |2 bkl | ||
| 084 | |a 44.90 |2 bkl | ||
| 084 | |a 44.91 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Dallerac, G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a S.12.02 Absence of D-serine results in abnormal dopamine–glutamate dialogue in the prefrontal cortex |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Tupin, F. |4 oth | |
| 700 | 1 | |a Morisot, N. |4 oth | |
| 700 | 1 | |a Levasseur, G. |4 oth | |
| 700 | 1 | |a Sacchi, S. |4 oth | |
| 700 | 1 | |a Fossat, P. |4 oth | |
| 700 | 1 | |a Rivet, J.M. |4 oth | |
| 700 | 1 | |a Oliet, S.H. |4 oth | |
| 700 | 1 | |a Coyle, J.T. |4 oth | |
| 700 | 1 | |a Pollegioni, L. |4 oth | |
| 700 | 1 | |a Snyder, S.H. |4 oth | |
| 700 | 1 | |a Contarino, A. |4 oth | |
| 700 | 1 | |a Millan, M.J. |4 oth | |
| 700 | 1 | |a Mothet, J.P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t European neuropsychopharmacology |d Amsterdam : Elsevier, 1990 |g 24(2014), 2, SUPPL vom: Okt., Seite 1-1 |w (DE-627)170623939 |w (DE-600)1082947-7 |w (DE-576)041592166 |x 0924-977X |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2014 |g number:2 |g month:10 |g supplement:SUPPL |g pages:1-1 |g extent:1 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PSY | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 77.00 |q AVZ |
| 936 | b | k | |a 44.90 |q AVZ |
| 936 | b | k | |a 44.91 |q AVZ |
| 936 | b | k | |a 44.38 |q AVZ |
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 24 |j 2014 |e 2 |c 10 |f SUPPL |h 1-1 |g 1 | ||